SPCG-4: a needed START to PIVOTal data to promote ...[J Natl Cancer Inst. 2008] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: J Natl Cancer Inst. 2008 Aug 20;100(16):1123-5. Epub 2008 Aug 11. Links

Comment on:: J Natl Cancer Inst. 2008 Aug 20;100(16):1144-54.

SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care.

PMID: 18695131 [PubMed - indexed for MEDLINE]

Related articles

Early versus delayed intervention for prostate cancer: the case for early intervention.
Nat Clin Pract Urol. 2007 Jul; 4(7):348-9. Epub 2007 Jun 12.

[Nat Clin Pract Urol. 2007]
ReviewThe role of radical prostatectomy in the treatment of cancer of the prostate.
Cancer Treat Res. 1989; 46:15-34.

[Cancer Treat Res. 1989]
On call. September 11 was an emotional day for all of us, but September 12 was a confusing day for me. I read two newspapers that reported on research in the New England Journal of Medicine. The New York Times headline said: "Prostate cancer surgery found to cut death risk," but the Washington Post announced: "Studies find no advantage to prostate cancer surgery." Which was right?
Harv Mens Health Watch. 2002 Dec; 7(5):8.

[Harv Mens Health Watch. 2002]
What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
J Urol. 2008 Nov; 180(5):1980-4; discussion 1985. Epub 2008 Sep 17.

[J Urol. 2008]
ReviewBenefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.
Ann Intern Med. 2008 Aug 5; 149(3):192-9.

[Ann Intern Med. 2008]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate canc...SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show